Sidley Austin

Torrey Cope

Deals
7
Latest
Apr 2026
Most deals in
Biotech

Firm

Deals by year
Torrey Cope: deals by year0720252026 YTD: 5 M&A2026 YTD: 2 Equity raisings72026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Torrey Cope was named on, most recent first
Apr 2026 Opus Genetics ––PlacementLegal adviser to the issuerAnnounced5.0Biotech+1Opus Genetics placement
Apr 2026 Obsidian Therapeutics ––PlacementLegal adviser to the issuerCompleted350.0Biotech+2Obsidian Therapeutics placement
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerLegal adviser to Galera TherapeuticsCompleted413.5Biotech+2Galera Therapeutics and Obsidian Therapeutics merger
Apr 2026 Exclusive global rights to TAK-063 (balipodect) Takeda Pharmaceutical Co.Axsome TherapeuticsAsset saleLegal adviser to Axsome Therapeutics (acquirer)Completed–Pharma+1Axsome Therapeutics acquisition of Exclusive global rights to TAK-063 (balipodect)
Mar 2026 Smartbox CareTech GroupVerdaneAcquisitionLegal adviser to Verdane (acquirer)Completed–Medtech+1Verdane acquisition of Smartbox
Feb 2026 Precision NeuroMed –Brainlab SEStakeLegal adviser to Precision NeuroMed (target)Completed–Biotech+2Brainlab SE stake in Precision NeuroMed
Jan 2026 Integrity Orthopaedics –Smith+NephewAcquisitionLegal adviser to Smith+Nephew (acquirer)Announced225.0MedtechSmith+Nephew acquisition of Integrity Orthopaedics

Deals where Torrey Cope is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.